![]() |
市場調查報告書
商品編碼
1954599
全球生物安全櫃市場:市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的分析、未來預測(2026-2034)Biological Safety Cabinet Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
2025 年全球生物安全櫃 (BSC) 市場規模為 3.3008 億美元,預計將從 2026 年的 3.4309 億美元增長至 2034 年的 4.9626 億美元,2026 年至 2034 年的複合年增長率 (CAGR) 為 4.70%。北美在 2025 年佔市場主導地位,市佔率達 38.46%。這主要得益於完善的實驗室基礎設施和日益活躍的研究活動。
生物安全櫃是一種密封的通風實驗室工作空間,旨在保護實驗室人員、環境和樣本免受生物危害和傳染性物質的侵害。 由於慢性病和傳染病的增加、製藥業研發的擴展以及人們對實驗室安全標準的日益重視,生物安全櫃的重要性顯著提升。
市場驅動因素
慢性病和傳染病的增加
全球傳染病數量的不斷增加是主要的成長驅動因素。根據世界衛生組織的數據,到2025年,全球每年將有約300萬至500萬例嚴重的季節性流感病例。此外,美國疾病管制與預防中心 (CDC) 的統計數據顯示,2023 年美國共有 9,633 例結核病病例,較 2022 年的 8,332 例呈上升趨勢,反映出診斷需求的不斷增長。
病患住院人數和診斷檢測量的增加推動了醫院和實驗室對生物安全櫃的需求。此外,製藥和生技公司研發管線的擴展也進一步推動了生物安全櫃的普及。
研發活動的擴展
到 2025 年,美國將有約 5,000 家製藥公司運營,對受控、無污染實驗室環境的需求持續增長。政府資助和生物安全措施的推廣也在加速產品的應用。
市場限制因子
設備成本高
生物安全櫃成本高是主要限制因素之一。根據2024年的行業數據,價格依配置不同,介於6,000美元至15,000美元之間。高級HEPA過濾器、紫外線系統、法規合規要求(美國NSF/ANSI 49標準,歐洲EN 12469標準)以及能耗都會顯著增加擁有成本。
監理與營運挑戰
嚴格的合規要求、頻繁的審核、認證續期以及過濾器和紫外線燈等組件的供應鏈限制,都構成了障礙,尤其對於中小製造商和新興市場而言。
市場機會
由於醫療基礎設施的不斷完善和研發投入的增加,巴西、墨西哥、中國和印度等新興經濟體預計將擁有巨大的成長潛力。政府為加強病原體研究設施和生物安全措施而採取的措施正在創造新的需求。
例如,巴西於2024年7月開始建造生物安全4級(BSL-4)實驗室,反映出該地區對傳染病研究日益增長的興趣。
市場趨勢
技術進步
先進感測器、人工智慧驅動的預測性維護、自動化合規性監控以及改進的生物安全櫃性能的整合正在改變傳統的生物安全櫃。模組化設計和增強的使用者介面正變得越來越普遍。
2025年5月,賽默飛世爾科技發表了1500系列II級A2型生物安全櫃,進一步豐富了其產品組合。同樣,LabConco 在 2024 年 8 月發布了重新設計的 Logic 生物安全櫃。
依類型
市場依類型分為 I 級、II 級和 III 級生物安全櫃。由於 II 級生物安全櫃能夠全面保護人員、產品和環境,因此在 2026 年,II 級生物安全櫃佔主導地位,市場佔有率高達 88.95%。
隨著實驗室安全措施日益嚴格,預計 I 級生物安全櫃將穩定成長。
依最終使用者
在研發活動不斷擴大和藥物開發計劃日益增多的推動下,預計生物技術和製藥公司將在 2026 年佔 39.72% 的市場佔有率。醫院、臨床實驗室和學術研究機構也是重要的需求來源。
北美
預計北美將在2025年以1.2696億美元的市場規模引領市場,並在2026年擴大至1.3243億美元。強勁的醫療保健支出(2023年美國人均醫療保健支出為14,570美元)和先進的實驗室基礎設施支撐了該地區的市場主導地位。光是美國市場預計在2026年就將達到1.1786億美元。
歐洲
在監管認證和研究設施擴張的推動下,歐洲市場預計將保持穩定成長。預計2026年,英國市場規模將達到2,475萬美元,德國市場規模將達2,858萬美元。
亞太地區
預計亞太地區將顯著成長。到2026年,隨著醫療保健投資的增加和宣傳活動的開展,預計中國市場規模將達到1,942萬美元,日本將達到1,169萬美元,印度將達到697萬美元。
拉丁美洲、中東和非洲
這些地區正在增加對醫療保健基礎設施的投資,並加強生物安全措施,從而支持市場穩步擴張。
The global biological safety cabinet (BSC) market was valued at USD 330.08 million in 2025 and is projected to grow from USD 343.09 million in 2026 to USD 496.26 million by 2034, registering a CAGR of 4.70% during 2026-2034. North America dominated the market in 2025, accounting for a 38.46% share, driven by strong laboratory infrastructure and increasing research activities.
Biological safety cabinets are enclosed, ventilated laboratory workspaces designed to protect laboratory personnel, the environment, and samples from biohazards and infectious agents. Their importance has grown significantly due to the rising burden of chronic and infectious diseases, expanding pharmaceutical R&D, and heightened awareness regarding laboratory safety standards.
Market Drivers
Rising Prevalence of Chronic and Infectious Diseases
The growing number of infectious diseases globally is a key growth driver. According to 2025 WHO data, approximately 3.0-5.0 million severe seasonal influenza cases occur annually worldwide. Additionally, CDC statistics reported 9,633 tuberculosis cases in 2023 in the U.S., compared to 8,332 in 2022, reflecting rising diagnostic needs.
Increasing patient admissions and diagnostic testing volumes have strengthened demand for biosafety cabinets across hospitals and laboratories. Furthermore, pharmaceutical and biotechnology companies are expanding R&D pipelines, further boosting adoption.
Growing Research & Development Activities
With around 5,000 pharmaceutical companies operating in the U.S. in 2025, the need for controlled and contamination-free laboratory environments continues to rise. Government funding and biosecurity preparedness initiatives are also accelerating product penetration.
Market Restraints
High Cost of Devices
One of the primary limiting factors is the high cost of biosafety cabinets. According to 2024 industry data, prices range between USD 6,000 and USD 15,000 depending on configuration. Advanced HEPA filtration, UV systems, regulatory compliance requirements (NSF/ANSI 49 in the U.S., EN 12469 in Europe), and energy consumption significantly increase ownership costs.
Regulatory and Operational Challenges
Stringent compliance requirements, frequent audits, certification updates, and supply chain constraints for components such as filters and UV lamps create barriers, particularly for smaller manufacturers and emerging markets.
Market Opportunities
Emerging nations such as Brazil, Mexico, China, and India present significant growth potential due to expanding healthcare infrastructure and increasing R&D investments. Government initiatives to strengthen pathogen research laboratories and biosafety preparedness are creating new demand avenues.
For instance, Brazil initiated construction of a Biosafety Level 4 (BSL-4) laboratory in July 2024, reflecting growing regional focus on infectious disease research.
Market Trends
Technological Advancements
The integration of advanced sensors, AI-enabled predictive maintenance, automated compliance monitoring, and improved containment features is transforming traditional biosafety cabinets. Modular designs and enhanced user interfaces are gaining popularity.
In May 2025, Thermo Fisher Scientific launched the 1500 Series Class II Type A2 BSC, strengthening its product portfolio. Similarly, in August 2024, Labconco introduced a redesigned Logic Biosafety Cabinet.
By Type
The market is segmented into Class I, Class II, and Class III cabinets. The Class II segment dominated in 2026 with an 88.95% market share, owing to its comprehensive protection capabilities for personnel, products, and the environment.
Class I cabinets are projected to grow steadily due to rising lab safety initiatives.
By End User
The biotechnology and pharmaceutical companies segment held a 39.72% share in 2026, driven by expanding R&D activities and increasing drug development initiatives. Hospitals & clinical laboratories and academic research institutes also contribute significantly to demand.
North America
North America led the market with a value of USD 126.96 million in 2025, increasing to USD 132.43 million in 2026. Strong healthcare spending (U.S. per capita healthcare expenditure of USD 14,570 in 2023) and advanced laboratory infrastructure support regional dominance. The U.S. market alone is projected to reach USD 117.86 million in 2026.
Europe
Europe is expected to grow steadily, supported by regulatory certifications and expanding research labs. The UK market is projected at USD 24.75 million in 2026, while Germany is expected to reach USD 28.58 million in 2026.
Asia Pacific
Asia Pacific is anticipated to register considerable growth. By 2026, China is projected to reach USD 19.42 million, Japan USD 11.69 million, and India USD 6.97 million, driven by expanding healthcare investments and awareness initiatives.
Latin America & Middle East & Africa
These regions are witnessing growing healthcare infrastructure investments and biosafety initiatives, supporting steady market expansion.
Competitive Landscape
Key players include Thermo Fisher Scientific Inc., Haier Biomedical, Esco Micro Pte. Ltd., Labconco, Kewaunee International Group, Baker Co., Germfree, and Biobase Biodusty. Companies are focusing on acquisitions, certifications, and innovative launches to expand global presence.
For example:
Conclusion
The global biological safety cabinet market demonstrates stable growth, increasing from USD 330.08 million in 2025 to USD 343.09 million in 2026, and projected to reach USD 496.26 million by 2034, growing at a 4.70% CAGR. Rising infectious disease prevalence, expanding pharmaceutical R&D, and technological advancements are key growth drivers. Although high costs and regulatory complexities present challenges, strong government funding, emerging market expansion, and innovation in AI-integrated biosafety systems are expected to sustain long-term market growth through 2034.
Segmentation By Type
By End User
By Geography